DRUG · Unmapped registry intervention
[18F]-FEOBV Radiotracer
Find medicine records ·
Find other trials using this name
Clinical trial
Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
NCT05231798
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedCholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Down Syndromeverified · MONDO: Down syndrome
Down Syndrome, Partial Trisomy 21unresolved
Alzheimer Diseaseverified · MONDO: Alzheimer disease
Interventions
Sponsors & collaborators
Vanderbilt University Medical Centerlead sponsor
Vanderbilt Kennedy Centercollaborator
Alzheimer's Associationcollaborator
Fondation Jérôme Lejeunecollaborator
National Institute on Aging (NIA)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05231798 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.